Dr. Matthew Ku discusses what CAR T-cell therapy is and how it works to target diseases like myelofibrosis.
Dr. Matthew Ku
Advertisement
Ku, a clinical and laboratory hematologist, is a professor and lymphoma stream lead at St Vincent’s Hospital, where he is also the principal investigator on multiple important clinical trials. He is a member of the Australasian Lymphoma Alliance, the Australasian Leukemia & Lymphoma Group and the American Society of Hematology.
Articles by Dr. Matthew Ku
Advertisement
Latest Updated Articles
Advertisement
Advertisement
